Scalable business for startups

+1 234 567 8910 info@domain.com

Veterinary Pharmaceuticals

Growing Demand in a Rapidly Expanding Market

The global veterinary pharmaceuticals industry is experiencing rapid growth,driven by increasing demand for animal healthcare products. With the growingsignificance of companion animals, the need for reliable veterinary medicines has surged. Recognizing this business potential, Rave Group has strategically invested in the veterinary pharmaceuticals sector to meet the demand and secure its role as a key supplier in this expanding market.

Growing Demand for Veterinary Pharmaceuticals

Increased Livestock Production:

As the global population rises, so does the demand for animal protein. According to the Food and Agriculture Organization (FAO), the world’s meat production is projected to increase by 40% by 2030 to meet growing consumption. This surge in livestock farming is driving the demand for pharmaceuticals that prevent and treat infectious diseases, improve animal welfare, and ensure food safety.

Companion Animal Care:

The trend of pet ownership continues to grow, especially in developed regions. A study by Grand View Research indicates that the global pet care market will reach USD 269 billion by 2025, with veterinary care accounting for a significant share. Pet owners are increasingly spending on veterinary care, including vaccines, medications, and preventive treatments, which is driving demand for high-quality veterinary pharmaceuticals.

Rave Group’s Investment in the Veterinary
Pharmaceuticals Sector

As a leading investment company, Rave Group has identified veterinary pharmaceuticals as a high-potential market and has strategically invested in this sector to meet rising global demand. Our focus is on supplying a wide range of generic and clinics, pharmacies, and animal healthcare providers have access to reliable, high-quality products.

Veterinary Medicines market was valued at USD 54.27 million in 2023 and is anticipated to reach USD 69.32 million by 2029 with a CAGR of 4.35% during the 2024-29 period. The group plans to foray into trading of generic and infectious medicines to target the ever-expanding market of UAE.

Learn More

Capitalizing on Market Opportunities

Product
Diversification

With growing awareness of animal health, there is rising demand for a broader range of products, from vaccines and antibiotics to specialized treatments for chronic conditions in both companion animals and livestock. Rave Group is actively looking for investment in a diverse product portfolio to meet these needs, ensuring that we can provide the right solutions for various markets.

Supply Chain
Efficiency

As demand grows, the ability to deliver medicines quickly and efficiently is becoming a competitive advantage. Rave Group’s investment in advanced logistics and distribution networks ensures that we can meet the increasing needs of veterinary clinics, hospitals, and farms across key markets, particularly in the UAE and surrounding regions.

Meeting the Needs of Emerging Markets

Emerging markets, especially in regions like Asia and Africa, are experiencing rapid growth in both livestock production and pet ownership.The demand for veterinary pharmaceuticals is expected to rise sharply in the UAE as well. Rave Group’s strategic investments are designed to tap into these high-growth regions, allowing us to be at the forefront of the market expansion.

Product
Diversification

With growing awareness of animal health, there is rising demand for a broader range of products, from vaccines and antibiotics to specialized treatments for chronic conditions in both companion animals and livestock. Rave Group is actively looking for investment in a diverse product portfolio to meet these needs, ensuring that we can provide the right solutions for various markets.

Supply Chain
Efficiency

As demand grows, the ability to deliver medicines quickly and efficiently is becoming a competitive advantage. Rave Group’s investment in advanced logistics and distribution networks ensures that we can meet the increasing needs of veterinary clinics, hospitals, and farms across key markets, particularly in the UAE and surrounding regions.

Meeting the Needs of Emerging Markets

Emerging markets, especially in regions like Asia and Africa, are experiencing rapid growth in both livestock production and pet ownership.The demand for veterinary pharmaceuticals is expected to rise sharply in the UAE as well. Rave Group’s strategic investments are designed to tap into these high-growth regions, allowing us to be at the forefront of the market expansion.

Scroll